PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6302997

Posttransfusion hepatitis in Spain. A prospective study.

J M Hernández·J Piqueras·A Carrera·J Triginer
View original source ↗Export metadata ↓

Abstract

The incidence of posttransfusion hepatitis was prospectively investigated in 230 cardiac surgery patients, 40 patients (17.4%) developed clinical and/or biological signs of hepatitis. In 10 cases (25%), the illness was due to hepatitis B virus infection. 1 patient (2.5%) had serological evidence of cytomegalovirus infection with clinical signs of hepatitis. In 29 cases (72.5%), the hepatitis was considered to be due to non-A, non-B agent(s). Of the 29 patients in this latter group, 16 have persistent transaminase elevations after 1 year, thus suggesting the development of chronic liver disease.

Explore related subjects

Cytomegalovirus InfectionsHepatitis AHepatitis BHepatitis CHepatitis, Viral, HumanHumansImmunization, PassiveSpainTransfusion ReactionJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J M Hernández, J Piqueras, A Carrera, J Triginer. 1983. Posttransfusion hepatitis in Spain. A prospective study.. https://doi.org/10.1111/j.1423-0410.1983.tb01889.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Etiology and impact of cytomegalovirus disease on solid organ transplant recipients.

PURPOSE: The characteristics, etiology, natural history, and direct and indirect effects of CMV disease in solid organ transplant recipients are described. SUMMARY: CMV is a common herpesvirus that may be present in the donor or recipient of a solid organ transplant. Even though it is rarely pathogenic in healthy patients, transplant recipients are at risk for CMV viremia and symptomatic disease due to their immune-suppressed status. In addition to symptoms directly attributed to active disease, CMV can have a variety of indirect effects. Indirect effects may include additional infectious complications, posttransplant lymphoproliferative disease, allograft rejection, allograft loss, or death. The three most prevalent risk factors for CMV infection are CMV seronegativity in a recipient of an organ from a CMV-seropositive donor, the type of organ transplanted, and the degree of immune suppression. CMV prophylaxis is effective at preventing disease, but may result in a delayed onset where CMV disease occurs once the prophylaxis is stopped. CONCLUSION: Knowledge of risk factors for CMV infection and disease, the natural history in transplant recipients, and its direct and indirect effects will help clinicians make appropriate decisions regarding the use of preventive strategies.

Cytomegalovirus Infections↗